1. Davit B, Braddy AC, Conner DP, Yu LX. International guidelines for bioequivalence of systemically available orally administered generic drug products: a survey of similarities and differences. AAPS J. 2013;15(4):974–90. doi: 10.1208/s12248-013-9499-x .
2. The International Generic Drug Regulators Pilot. IGDRP generic drug product regulatory gap analysis. WHO Drug Inf. 2016;30(3):361–9.
3. Kanfer I, Shargel L. Generic Drug Product Development: International Regulatory Requirements for Bioequivalence. 1st ed. New York: CRC Press; 2010.
4. Health Canada. Canadian Reference Product. 1995. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/pol/crp_prc_pol-eng.php . Accessed 5 Jan 2017.
5. Therapeutic Goods Administration. Choice of the reference product for bioequivalence of generic medicines. 2015. https://www.tga.gov.au/book/156-choice-reference-product-bioequivalence-generic-medicines . Accessed 5 Jan 2017.